Individual genetic profiles of taste receptors, circadian rhythms in hormonal sensitivity, and personalized microbiome-gustatory interactions will pave the way for tailored interventions
1 Similarly, the active ingredient tirzepatide is marketed by Eli Lilly as two separate drugs under the brand names Mounjaro (injection for diabetes, approved in 2022) and Zepbound (injection for weight loss, approved in 2023)
Furthermore, it has the potential to transform metabolic medicine, with applications extending beyond weight loss
Liposomal glutathione: This form of glutathione is more bioavailable and easily absorbed by the body
Another crucial target involved in metabolic diseases and cognitive impairment is the mammalian target of rapamycin (mTOR)
Organ and tissue growth concerns Because IGF-1 signaling affects cellular growth and proliferation throughout the body and not exclusively in skeletal muscle, there is concern that long-term use of IGF-1 could result in increased growth of other tissues/organs in the body